Atea Pharmaceuticals Stock Price History

AVIR Stock  USD 2.99  0.01  0.33%   
If you're considering investing in Atea Stock, it is important to understand the factors that can impact its price. As of today, the current price of Atea Pharmaceuticals stands at 2.99, as last reported on the 31st of January, with the highest price reaching 3.15 and the lowest price hitting 2.96 during the day. Atea Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0527, which signifies that the company had a -0.0527 % return per unit of standard deviation over the last 3 months. Atea Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Atea Pharmaceuticals' mean deviation of 2.04, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide.
  
Atea Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0527

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsAVIR

Estimated Market Risk

 2.83
  actual daily
25
75% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average Atea Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atea Pharmaceuticals by adding Atea Pharmaceuticals to a well-diversified portfolio.

Atea Pharmaceuticals Stock Price History Chart

There are several ways to analyze Atea Stock price data. The simplest method is using a basic Atea candlestick price chart, which shows Atea Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 6, 20243.58
Lowest PriceDecember 5, 20242.93

Atea Pharmaceuticals January 31, 2025 Stock Price Synopsis

Various analyses of Atea Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Atea Stock. It can be used to describe the percentage change in the price of Atea Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Atea Stock.
Atea Pharmaceuticals Price Rate Of Daily Change 1.00 
Atea Pharmaceuticals Price Daily Balance Of Power(0.05)
Atea Pharmaceuticals Price Action Indicator(0.07)

Atea Pharmaceuticals January 31, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Atea Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Atea Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Atea Stock and then apply it to test your longer-term investment strategies against Atea.

Atea Stock Price History Data

The price series of Atea Pharmaceuticals for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 has a statistical range of 0.65 with a coefficient of variation of 5.23. The prices are distributed with arithmetic mean of 3.24. The median price for the last 90 days is 3.25. The company had 1:6 stock split on 9th of November 2012. Atea Pharmaceuticals issued dividends on 2012-11-09.
OpenHighLowCloseVolume
01/31/2025
 3.00  3.15  2.96  2.99 
01/30/2025 3.00  3.15  2.96  2.99  498,889 
01/29/2025 3.09  3.12  2.97  3.00  420,803 
01/28/2025 3.16  3.16  3.06  3.10  367,186 
01/27/2025 3.14  3.20  3.10  3.15  306,058 
01/24/2025 3.10  3.22  3.06  3.16  350,620 
01/23/2025 3.08  3.18  3.05  3.10  482,521 
01/22/2025 3.25  3.25  3.11  3.12  514,170 
01/21/2025 3.37  3.39  3.24  3.24  320,450 
01/17/2025 3.40  3.49  3.36  3.37  337,674 
01/16/2025 3.31  3.41  3.27  3.33  406,557 
01/15/2025 3.24  3.32  3.16  3.32  679,697 
01/14/2025 3.21  3.25  3.11  3.15  424,731 
01/13/2025 3.22  3.27  3.12  3.20  766,648 
01/10/2025 3.33  3.37  3.23  3.27  596,299 
01/08/2025 3.35  3.42  3.33  3.34  356,810 
01/07/2025 3.37  3.51  3.34  3.36  382,712 
01/06/2025 3.52  3.52  3.37  3.40  583,633 
01/03/2025 3.46  3.60  3.46  3.52  282,224 
01/02/2025 3.38  3.54  3.37  3.42  365,939 
12/31/2024 3.33  3.40  3.33  3.35  326,618 
12/30/2024 3.30  3.38  3.27  3.33  410,083 
12/27/2024 3.27  3.36  3.23  3.33  640,959 
12/26/2024 3.23  3.29  3.19  3.29  333,048 
12/24/2024 3.22  3.28  3.20  3.25  174,762 
12/23/2024 3.19  3.30  3.19  3.24  403,144 
12/20/2024 3.12  3.32  3.11  3.19  1,242,722 
12/19/2024 3.16  3.23  3.10  3.13  1,375,641 
12/18/2024 3.15  3.27  3.11  3.16  477,947 
12/17/2024 3.12  3.17  3.04  3.16  517,029 
12/16/2024 3.20  3.24  3.09  3.10  1,587,735 
12/13/2024 2.93  2.97  2.88  2.93  256,573 
12/12/2024 2.96  3.08  2.91  2.95  300,845 
12/11/2024 2.90  2.99  2.88  2.96  257,799 
12/10/2024 3.01  3.03  2.75  2.94  909,469 
12/09/2024 2.94  3.07  2.89  3.02  303,878 
12/06/2024 2.94  2.94  2.87  2.94  308,589 
12/05/2024 3.07  3.11  2.86  2.93  494,680 
12/04/2024 3.50  3.50  3.11  3.12  653,286 
12/03/2024 3.49  3.50  3.46  3.48  152,760 
12/02/2024 3.40  3.54  3.38  3.50  140,741 
11/29/2024 3.37  3.49  3.34  3.42  119,282 
11/27/2024 3.37  3.50  3.37  3.46  209,782 
11/26/2024 3.38  3.40  3.27  3.30  155,141 
11/25/2024 3.38  3.48  3.37  3.40  183,124 
11/22/2024 3.27  3.39  3.24  3.37  148,948 
11/21/2024 3.17  3.26  3.16  3.25  146,034 
11/20/2024 3.12  3.16  3.10  3.16  182,020 
11/19/2024 3.13  3.17  3.12  3.14  94,277 
11/18/2024 3.22  3.32  3.16  3.17  119,274 
11/15/2024 3.35  3.35  3.18  3.22  313,823 
11/14/2024 3.38  3.43  3.31  3.31  208,898 
11/13/2024 3.39  3.48  3.35  3.35  207,985 
11/12/2024 3.38  3.43  3.32  3.33  265,309 
11/11/2024 3.50  3.55  3.33  3.36  243,701 
11/08/2024 3.49  3.57  3.43  3.50  170,075 
11/07/2024 3.51  3.60  3.42  3.44  282,101 
11/06/2024 3.45  3.62  3.43  3.58  380,546 
11/05/2024 3.32  3.37  3.29  3.36  93,437 
11/04/2024 3.27  3.41  3.25  3.35  137,566 
11/01/2024 3.28  3.31  3.25  3.29  77,369 

About Atea Pharmaceuticals Stock history

Atea Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Atea is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Atea Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Atea Pharmaceuticals stock prices may prove useful in developing a viable investing in Atea Pharmaceuticals
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts. Atea Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 63 people.

Atea Pharmaceuticals Stock Technical Analysis

Atea Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Atea Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Atea Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Atea Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Atea Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Atea Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Atea to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Atea Stock Analysis

When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.